API OMR GLOBAL

Menu
Menu

Agomelatine Market

  • Home
  • »
  • Agomelatine Market

Agomelatine Market Size, Share & Industry Analysis, By Source (Synthetic Chemical Synthesis, Enzymatic Synthesis, Hybrid Production), By Key End-Use Industries (Pharmaceuticals, Psychiatry & Mental Health, Neurology & Sleep Disorders Treatment, Research & Development, Clinical Diagnostics), and Forecast, 2025-2035

The Agomelatine market is expected to grow steadily at a CAGR of 6.2% between 2025-2035, driven by rising demand in the pharmaceutical and mental health sectors. Agomelatine is a novel antidepressant that regulates melatonin and serotonin levels, making it highly effective for treating major depressive disorder and improving sleep quality. Regional segments with advanced healthcare infrastructure, particularly North America and Europe, dominate the market due to strong regulatory support, widespread awareness, and high adoption rates. Meanwhile, demand in Asia-Pacific, particularly in China and India, is increasing as mental health awareness and healthcare investments rise. This report explores key trends in the Agomelatine market, covering production, pricing, and trade insights. Given its role in treating depression and sleep disorders, Agomelatine continues to be a vital medication in global mental healthcare.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Speak to an Expert

Report Scope & Segmentation

  1. Introduction
    • Overview of Agomelatine
    • Key Applications & Industry Use Cases
    • Market Scope & Study Objectives
  2. Market Overview
    • Global Market Size & Growth Trends (Historical & Forecast)
    • Market Value & Revenue Analysis
    • Demand-Supply Dynamics
  3. Segmental Outlook
    • By Source
      • Synthetic Chemical Synthesis (Produced through controlled organic synthesis using laboratory-based processes)
      • Enzymatic Synthesis (Utilizing biocatalysts for a greener and more sustainable production approach)
      • Hybrid Production (Combines chemical synthesis with biocatalytic steps for enhanced yield and sustainability)
    • Key End-Use Industries
      • Pharmaceuticals
      • Psychiatry & Mental Health
      • Research & Development
      • Neurology & Sleep Disorders Treatment
      • Clinical Diagnostics
  4. Price Analysis
    • Current Price Trends (Per kg & Per Ton)
    • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
    • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  5. Production & Supply Volume
    • Global Production Capacity & Key Manufacturers
    • Production Process & Technological Developments
    • Raw Material Analysis
  6. Trade Analysis (Import & Export)
    • Major Exporting & Importing Countries
    • Trade Volume & Value Statistics
    • Impact of Trade Regulations & Policies
  7. Regional Analysis
    • North America (US and Canada)
    • Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
    • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
    • Rest of the World (Latin America and Middle East and Africa)
  8. Competitive Landscape
    • Top Global Manufacturers & Market Share
    • Company Profiles & Key Developments
    • Mergers, Acquisitions & Investments
  9. Regulatory & Compliance Factors
    • FDA, REACH, and Other Regulatory Frameworks
    • Environmental & Safety Considerations
    • Emerging Policies Impacting Market Growth
  10. Conclusion & Strategic Recommendations
    • Key Takeaways for Stakeholders
    • Market Entry Strategies
Facebook Twitter Youtube
  • Frequently Asked Questions
What is Agomelatine?
Agomelatine is an antidepressant primarily used in the treatment of major depressive disorder (MDD). It functions as a melatonergic agonist and a selective serotonin antagonist, which helps regulate circadian rhythms and improve mood without many of the common side effects associated with traditional antidepressants.
What is the market growth of Agomelatine?
The global Agomelatine market is anticipated to grow at a CAGR of % from 05 to 05, driven by increasing diagnoses of depression and mood disorders, growing awareness of mental health treatments, and rising preference for antidepressants with fewer side effects.
What are the drivers of the Agomelatine Market?
Key drivers include the global rise in mental health concerns, a shift toward therapies with novel mechanisms of action, patient preference for better-tolerated medications, and expanding regulatory approvals and marketing in emerging regions.
Who are the key players operating in the Agomelatine Market?
Major players in the Agomelatine market include Servier Laboratories (the original developer and marketer of the drug under the brand Valdoxan), along with other pharmaceutical companies producing generic versions or distributing in local markets.
Which region would exhibit the fastest growth in the Agomelatine Market?
Asia-Pacific is expected to exhibit the fastest growth in the Agomelatine market during 05–05, owing to growing awareness of mental health, increasing healthcare access, and rising demand for innovative antidepressants in countries such as India, China, and South Korea.
  • Choose License Type
$2500/- Single User License
$4000/- Multi User License
$5500/- Corporate License
  • Why Choose us?
  • Experienced in market research and consulting.
  • Seasoned professionals with diverse industry knowledge.
  • Proven track record in delivering valuable insights.
  • Tailored methodologies for unique client needs.
  • End-to-end services: market analysis, competitor intelligence, consumer behavior, and strategic recommendations.
  • Latest tools and tech for data collection, analysis, and visualization.
  • Embrace of AI and machine learning for deeper insights.
  • Global capabilities and extensive network.
  • In-depth understanding of international markets, trends, and regulations.
  • Dedicated to addressing specific client needs and goals.
  • Focus on delivering value through efficient research outcomes.
  • Recent posts

How can we help you?

Reach out to discuss how our team can help your business achieve real results.

Contact Person

Mr. Anurag Tiwari

Call Us

+91-780-304-0404

Mail Us

info@omrglobal.com